Functional toll-like receptor 3 expressed by oral squamous cell carcinoma induced cell apoptosis and decreased

Zhifeng He1, Xiaofeng Huang1, Yanhong Ni1

  • 1Central Laboratory of Stomatology, Institute and Hospital of Stomatology, Nanjing University Medical School, Nanjing University, Nanjing, China.

Abstract

Insights

Toll-like receptor 3 (TLR3) is present in oral squamous cell carcinoma (OSCC). Activating TLR3 with Poly(I:C) reduces OSCC cell viability and migration, suggesting TLR3 as a potential immunotherapy target.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Oral squamous cell carcinoma (OSCC) is a prevalent malignancy.
  • The role of pattern recognition receptors, such as toll-like receptors (TLRs), in OSCC is not fully understood.

Purpose of the Study:

  • To investigate the expression and functional role of toll-like receptor 3 (TLR3) in oral squamous cell carcinoma (OSCC).

Main Methods:

  • TLR3 expression was assessed in primary OSCC tissues and cell lines (SCC4, CAL27).
  • OSCC cell lines were treated with polyinosinic-polycytidylic acid [Poly(I:C)] to activate TLR3.
  • Changes in cytokine expression, cell viability, apoptosis, and migration were analyzed.

Main Results:

  • TLR3 was detected in both OSCC tissue and cell lines.
  • Poly(I:C) stimulation upregulated cytokine expression in OSCC cells.
  • Activation of TLR3 led to decreased cell viability (via suppressed proliferation and induced apoptosis) and reduced cell migration.
  • Poly(I:C)-TLR3-induced apoptosis was dependent on caspase-3.

Conclusions:

  • TLR3 is expressed in OSCC and its activation influences cancer cell behavior.
  • TLR3 may play a role in OSCC development.
  • TLR3 represents a potential therapeutic target for OSCC immunotherapy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K